期刊
JOURNAL OF INFECTIOUS DISEASES
卷 201, 期 1, 页码 5-14出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/648592
关键词
-
资金
- Pediatric Dengue Vaccine Initiative [VE-1]
- National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [HHSN266200400001C]
Background. Dengue is the most prevalent mosquito-borne viral disease in humans and a major urban public health problem worldwide. Methods. A prospective cohort study of similar to 3800 children initially aged 2-9 years was established in Managua, Nicaragua, in 2004 to study the natural history of dengue transmission in an urban pediatric population. Blood samples from healthy subjects were collected annually prior to the dengue season, and identification of dengue cases occurred via enhanced passive surveillance at the study health center. Results. Over the first four years of the study, seroprevalence of anti-dengue virus (DENV) antibodies increased from 22%-40% in the 2-year-old cohort and 90%-95% in the 9-year-old cohort. The incidence of symptomatic dengue cases and the ratio of inapparent to symptomatic DENV infection varied substantially from year to year. The switch in dominant transmission from DENV-1 to DENV-2 was accompanied by an increase in disease severity but, paradoxically, a decrease in transmission. Phylogeographic analysis of full-length DENV-2 sequences revealed strong geographic clustering of dengue cases. Conclusions. This large-scale cohort study of dengue in the Americas demonstrates year-to-year variation of dengue within a pediatric population, revealing expected patterns in transmission while highlighting the impact of interventions, climate, and viral evolution.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据